Jason Friedman

Jason Friedman is a Senior Scientist at Just - Evotec Biologics, overseeing a team focused on early-phase upstream development and technology initiatives for continuous purification platforms since May 2023. Prior experience includes serving as the upstream lead for AAV viral vector platform development at Bristol Myers Squibb, where Jason facilitated process transfers from January 2021 to May 2023. Jason's background also comprises roles at AGC Biologics in upstream process development for CHO-derived therapeutics and research technician responsibilities at The Research Corporation of the University of Hawai'i, enhancing skills in data analysis and fieldwork. Academically, Jason holds an M.S. in Biological Oceanography from the University of Hawaii at Manoa and a B.S. in Biological Sciences from Cornell University.